Nantahala Capital Management
$1.7B 13F equity value
149 Holdings
Quarter ended June 30, 2026
The latest 13F on file for Nantahala Capital Management covers the quarter ended June 30, 2026. Institutional managers report holdings quarterly to the SEC, so each filing is a snapshot of positions held on that date.
Top Holdings
| Ticker | Company | Shares | Value | Weight |
|---|---|---|---|---|
| TBBK | BANCORP INC DEL | 1,239,887 | $78M | 4.7% |
| BVS | BIOVENTUS INC | 6,000,279 | $57M | 3.4% |
| HGV | HILTON GRAND VACATIONS INC | 1,033,170 | $54M | 3.3% |
| SVRA | SAVARA INC | 6,976,810 | $43M | 2.6% |
| ETON | ETON PHARMACEUTICALS INC | 1,175,951 | $43M | 2.6% |
| AMRX | AMNEAL PHARMACEUTICALS INC | 2,268,751 | $39M | 2.4% |
| EOLS | EVOLUS INC | 5,602,021 | $39M | 2.4% |
| AVTX | AVALO THERAPEUTICS INC | 1,862,250 | $34M | 2.1% |
| LBRX | LB PHARMACEUTICALS INC | 1,052,894 | $34M | 2.1% |
| AVR | ANTERIS TECHNOLOGIES GLOBAL | 3,383,335 | $33M | 2.0% |
Track Nantahala Capital Management's 13F portfolio: $1.7B in reported holdings, 149 positions. Top holdings and quarterly changes on SentiSense.
This page is powered by the SentiSense API: GET /api/v1/institutional/institution/{slugOrCik}